Artur Figueirinha

Dr. Artur Figueirinha

orcid

Research Focus & Metrics

Academic Career Length

27Years (2000-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
24 July 2020 in Marine Drugs
Verified
Journal Article
Open access
PDF file
João CotasJoão Cotas
João Cotas
ALAdriana Leandro
Adriana Leandro
PMPedro Manuel Monteiro
Pedro Manuel Monteiro
DPDiana Pacheco
Diana Pacheco
AFArtur Figueirinha
Artur Figueirinha
Leonel PereiraLeonel Pereira
Leonel Pereira
Seaweeds have attracted high interest in recent years due to their chemical and bioactive properties to find new molecules with valuable applications for humankind. Phenolic compounds are the group of metabolites with the most structural variation and the highest content in seaweeds. The most researched seaweed polyphenol class is the phlorotannins, which are specifically synthesized by brown seaweeds, but there are other polyphenolic compounds, such as bromophenols, flavonoids, phenolic terpenoids, and mycosporine-like amino acids. The compounds already discovered and characterized demonstrate a full range of bioactivities and potential future applications in various industrial sectors. This review focuses on the extraction, purification, and future applications of seaweed phenolic compounds based on the bioactive properties described in the literature. It also intends to provide a comprehensive insight into the phenolic compounds in seaweed.

1 October 2008 in Food Chemistry
Verified
Journal Article
Closed access
AFArtur Figueirinha
Artur Figueirinha
APAntónio Paranhos
António Paranhos
JPJosé J. Pérez-Alonso
José J. Pérez-Alonso
Celestino Santos-BuelgaCelestino Santos-Buelga
Celestino Santos-Buelga
MBMaria Teresa Batista
Maria Teresa Batista


1 January 2011 in Journal of Ethnopharmacology
Verified
Journal Article
Closed access
Vera FranciscoVera Francisco
Vera Francisco
AFArtur Figueirinha
Artur Figueirinha
Bruno Miguel NevesBruno Miguel Neves
Bruno Miguel Neves
CGCarmen García-Rodríguez
Carmen García-Rodríguez
MLMaria Celeste Lopes
Maria Celeste Lopes
MBMaria Teresa Batista
Maria Teresa Batista

1 September 2017 in Food Research International
Verified
Journal Article
Closed access
ACAna Rita Carvalho
Ana Rita Carvalho
Gustavo CostaGustavo Costa
Gustavo Costa
AFArtur Figueirinha
Artur Figueirinha
JLJoana Liberal
Joana Liberal
JPJoão A. V. Prior
João A. V. Prior
MBMaria Teresa Batista
Maria Teresa Batista

1 June 2010 in Journal of Medicinal Food
Verified
Journal Article
Closed access
AFArtur Figueirinha
Artur Figueirinha
Maria Teresa CruzMaria Teresa Cruz
Maria Teresa Cruz
Vera FranciscoVera Francisco
Vera Francisco
MLM. Celeste Lopes
M. Celeste Lopes
MBMaria Teresa Batista
Maria Teresa Batista
Cymbopogon citratus , an herb known worldwide as lemongrass, is widely consumed as an aromatic drink, and its fresh and dried leaves are currently used in traditional cuisine. However, little is known about the mechanism of action of C. citratus , namely, the anti-inflammatory effects of its dietary components. Because nitric oxide (NO), produced in large quantities by activated inflammatory cells, has been demonstrated to be involved in the pathogenesis of acute and chronic inflammation, we evaluated the effects of the infusion of dried leaves from C. citratus , as well as its polyphenolic fractions—flavonoid-, tannin-, and phenolic acid-rich fractions (FF, TF, and PAF, respectively)—on the NO production induced by lipopolysaccharide (LPS) in a skin-derived dendritic cell line (FSDC). C. citratus infusion significantly inhibited the LPS-induced NO production and inducible NO synthase (iNOS) protein expression. All the polyphenolic fractions tested also reduced the iNOS protein levels and NO production stimulated by LPS in FSDC cells, without affecting cell viability, with the strongest effects being observed for the fractions with mono- and polymeric flavonoids (FF and TF, respectively). Our results also indicated that the anti-inflammatory properties of FF are mainly due to luteolin glycosides. In conclusion, C. citratus has NO scavenging activity and inhibits iNOS expression and should be explored for the treatment of inflammatory diseases, in particular of the gastrointestinal tract.